Table 2. Patient's demographics according to ASCT2 expression in NGH cohort.
| |
|
All (n=104) |
AC (n=66) |
Non-AC (n=38) |
||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Variable | Total (n=104) (%) | High (n=66) | Low (n=38) | P-value | High (n=36) | Low (n=30) | P-value | High (n=30) | Low (n=8) | P-value |
|
Age | ||||||||||
| ⩽65 years | 31 | 23 | 8 | 0.182 | 18 | 7 | 0.041 | 5 | 1 | >0.999 |
| >65 years |
73 |
43 |
30 |
|
18 |
23 |
|
25 |
7 |
|
|
Sex | ||||||||||
| Male | 64 | 46 | 18 | 0.035 | 19 | 12 | 0.332 | 27 | 6 | 0.279 |
| Female |
40 |
20 |
20 |
|
17 |
18 |
|
3 |
2 |
|
|
Smoking | ||||||||||
| Yes | 66 | 45 | 21 | 0.209 | 17 | 14 | >0.999 | 28 | 7 | 0.518 |
| No |
38 |
21 |
17 |
|
19 |
16 |
|
2 |
1 |
|
|
p-Stage | ||||||||||
| I or II | 80 | 44 | 36 | 0.001 | 20 | 30 | <0.001 | 24 | 6 | >0.999 |
| III or IV |
24 |
22 |
2 |
|
16 |
0 |
|
6 |
2 |
|
|
T factor | ||||||||||
| T1-2 | 93 | 55 | 38 | 0.006 | 27 | 30 | 0.003 | 28 | 8 | >0.999 |
| T3-4 |
11 |
11 |
0 |
|
9 |
0 |
|
2 |
0 |
|
|
N factor | ||||||||||
| N0 | 71 | 40 | 31 | 0.030 | 18 | 25 | 0.009 | 22 | 6 | >0.999 |
| N1-2 |
33 |
26 |
7 |
|
18 |
5 |
|
8 |
2 |
|
|
Histology | ||||||||||
| AC | 66 | 36 | 30 | 0.019 | — | — | — | — | — | — |
| Non-AC |
38 |
30 |
8 |
|
|
|
|
|
|
|
|
Lymphatic permeation | ||||||||||
| Positive | 59 | 44 | 15 | 0.008 | 27 | 12 | 0.006 | 17 | 3 | 0.438 |
| Negative |
45 |
22 |
23 |
|
9 |
18 |
|
13 |
5 |
|
|
Vascular invasion | ||||||||||
| Positive | 57 | 44 | 13 | 0.002 | 17 | 8 | 0.126 | 27 | 5 | 0.094 |
| Negative |
47 |
22 |
25 |
|
19 |
22 |
|
3 |
3 |
|
|
CD98 | ||||||||||
| High | 57 | 46 | 11 | <0.001 | 20 | 4 | <0.001 | 26 | 7 | >0.999 |
| Low |
47 |
20 |
27 |
|
16 |
26 |
|
4 |
1 |
|
|
Ki-67 | ||||||||||
| High | 46 | 42 | 10 | <0.001 | 13 | 5 | 0.099 | 29 | 5 | 0.024 |
| Low |
58 |
24 |
28 |
|
23 |
25 |
|
1 |
3 |
|
|
CD34 | ||||||||||
| High | 47 | 38 | 9 | 0.001 | 22 | 5 | <0.001 | 16 | 4 | >0.999 |
| Low |
57 |
28 |
29 |
|
14 |
25 |
|
14 |
4 |
|
|
p-mTOR | ||||||||||
| High | 41 | 30 | 11 | 0.144 | 26 | 11 | 0.006 | 4 | 0 | 0.559 |
| Low | 63 | 36 | 27 | 10 | 19 | 26 | 8 | |||
Abbreviations: AC=adenocarcinoma; ASCT2=ASC amino-acid transporter 2; NGH=Nishi-Gunma Hospital; non-AC=non-adenocarcinoma; p-mTOR=phosphorylation of mammalian target of rapamycin; p-stage=pathological stage.
Bold entries show statistically significant difference.